Results 191 to 200 of about 793,336 (333)

An Integrative Drug-Induced Transcriptomic Analysis Identifies Novel MYC Antagonists and Potential Synergistic Drug Combinations. [PDF]

Mol Carcinog
Aceto A, Wang Y, Yang D.
europepmc   +1 more source

Transcriptional network analysis of PTEN‐protein‐deficient prostate tumors reveals robust stromal reprogramming and signs of senescent paracrine communication

Molecular Oncology, EarlyView.
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice, Jose I. Lopez, Aitziber Ugalde‐Olano, Maite Zufiaurre, Ianire Astobiza, Natalia Martin‐Martin, Laura Bozal‐Basterra, Saioa Garcia‐Longarte, Amaia Zabala‐Letona, Sofia Rey, Aida Santos‐Martin, Miguel Unda, Ana Loizaga‐Iriarte, Mariona Graupera, Paolo Nuciforo, Arkaitz Carracedo, Isabel Mendizabal   +16 more
wiley   +1 more source

Novel Mixed Cancer-Cell Models Designed to Capture Inter-Patient Tumor Heterogeneity for Accurate Evaluation of Drug Combinations. [PDF]

Int J Mol Sci
Jena S, Kim DC, Lee AM, Zhang W, Zhan K, Elmorsi RM, Li Y, Dehm SM, Huang RS.   +8 more
europepmc   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

CDFA: Calibrated deep feature aggregation for screening synergistic drug combinations. [PDF]

Front Pharmacol
Kang X, Liu X, Zou Q, Li T, Luo X.
europepmc   +1 more source

Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinations [PDF]

, 2015
W. Joost Lesterhuis, Catherine Rinaldi, Anya C. Jones, Esdy Rozali, Ian M. Dick, Andrea Khong, Louis Boon, Bruce Robinson, Anna K. Nowak, Anthony Bosco, Richard Lake   +10 more
openalex   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source

Selective Identification of Allosteric Inhibitors and Co-Drug Combinations Targeting Kinases by Using a Nanopore Tweezer Approach. [PDF]

ACS Nano
Li F, Foster JC, Nguyen L, Chen M.
europepmc   +1 more source

Soil-transmitted helminthiasis: the efficacy of recommended drugs, new drugs and combinations

, 2017
Wendelin Moser
openalex   +1 more source

Identification of drug combinations administered by continuous subcutaneous infusion that require analysis for compatibility and stability [PDF]

, 2017
Andrew Dickman, Matthew Bickerstaff, Richard Jackson, Jennifer Schneider, Stephen Mason, John Ellershaw   +5 more
openalex   +1 more source